The test is being developed at Llanelli's Prince Phillip Hospital with the help of Singleton Oncology and the University of Swansea.
During recent trials, nearly half of patients who were initially recommended for chemotherapy and endocrine therapy, had their treatment changed to endocrine therapy alone.
This test will have a major impact on the lives of many women, allowing them to get on with their lives following breast cancer surgery rather than having to go through four months of chemotherapy."
The 'Oncotype DX' test, which is only for women with early breast cancer, will give clinicians a clearer idea of the risk and benefit of chemotherapy.
More top news
Autumn is not going to go out with a whimper! Turning very wet and windy over the next few days, but remaining mild!
Rebecca Newcombe charged between £25 to £580 for holidays and arranged to hand over keys for caravans - but would then fail to show up.
More trains will be laid on between the Cynon Valley and Cardiff this Christmas.